Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Eton Pharmaceuticals Received FDA Acceptance Of New Drug Application For ET-400

Author: Benzinga Newsdesk | July 15, 2024 04:07pm

- Prescription Drug User Fee Act (PDUFA) target action date is February 28, 2025 -

 

- Product has patent protection through 2043 -

Posted In: ETON

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist